V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003264 | 210008895 | 1.68 | 58.05 | null | 2018-12-31 | 2019-01-20 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100468383 |
| 210003268 | 210008896 | 1.52 | 59.6 | Adjuvant (A) | 2017-12-22 | 2018-03-13 | Capecitabine | null | N | CAPECITABINE | 100886552 |
| 210003269 | 210008897 | 1.7 | 127 | Palliative (P) | 2020-11-08 | 2021-03-25 | FEC + DOCETAXEL | 02 | N | CARBOPLATIN + DOCETAXEL | 100582502 |
| 210003270 | 210008898 | null | null | null | 2016-09-28 | 2016-10-07 | Paclitaxel albumin (Abraxane) 21day | N | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100006670 |
| 210003271 | 210008899 | 1.57 | 56.8 | Adjuvant (A) | 2017-12-28 | 2017-12-30 | Capecitabine | 02 | N | CAPECITABINE | 100350490 |
| 210003273 | 210008900 | 1.63 | 50.5 | Palliative (P) | 2019-02-08 | 2019-05-27 | Eribulin | 02 | null | ERIBULIN | 101807706 |
| 210003277 | 210008903 | null | null | null | null | 2019-07-30 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100163578 |
| 210003280 | 210008905 | 1.68 | 68.08 | Neo-adjuvant (N) | 2018-05-30 | 2018-09-01 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101310569 |
| 210003281 | 210008906 | 1.67 | 74.4 | null | null | 2017-03-14 | Bortezomib + Cyclophos + Dex | 02 | null | ATEZOLIZUMAB | 100244001 |
| 210003283 | 210008908 | 1.67 | 51 | null | null | 2019-02-07 | null | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL + TRASTUZUMAB | 101017890 |
| 210003284 | 210008909 | 1.73 | 89 | Adjuvant (A) | 2016-01-28 | 2016-02-09 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 101831786 |
| 210003287 | 210008910 | 1.59 | 82.7 | Palliative (P) | null | 2018-08-31 | Capecitabine | N | N | CAPECITABINE | 100051775 |
| 210003289 | 210008911 | 1.72 | 60.7 | Neo-adjuvant (N) | 2017-07-24 | 2017-07-27 | PACLITAXEL + TRASTUZUMAB | 02 | N | PACLITAXEL + TRASTUZUMAB | 101222992 |
| 210003295 | 210008914 | 1.62 | 66.3 | Curative (C) | null | 2018-08-15 | null | 02 | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101706298 |
| 210003296 | 210008915 | 1.72 | 70.3 | null | 2020-01-22 | 2020-05-02 | Capecitabine | null | null | CAPECITABINE | 100768044 |
| 210003298 | 210008917 | null | null | null | null | 2020-02-22 | null | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL | 100231330 |
| 210003300 | 210008919 | 1.54 | 69.2 | Neo-adjuvant (N) | 2017-08-31 | 2017-09-02 | EC | 02 | N | EC | 100201936 |
| 210003304 | 210008923 | 1.55 | 107.2 | null | 2019-01-14 | 2019-01-17 | TCH (21 day Trastuzumab) Maint | null | null | CAPECITABINE | 100561238 |
| 210003305 | 210008924 | null | null | null | null | 2019-10-03 | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL + Pertuzumab + Trastuzumab | 01 | null | TRASTUZUMAB EMTANSINE | 100432458 |
| 210003307 | 210008925 | 1.61 | 69.4 | null | 2015-12-02 | 2020-01-09 | Capecitabine | 02 | null | CAPECITABINE | 100133164 |
| 210003308 | 210008926 | 1.66 | 55 | Palliative (P) | 2017-10-29 | 2019-08-21 | Letrozole + Palbociclib | null | N | PACLITAXEL + TRASTUZUMAB | 101739553 |
| 210003309 | 210008927 | 1.6 | 54.95 | Curative (C) | 2018-12-20 | 2019-02-27 | null | null | null | LETROZOLE + PALBOCICLIB | 100412354 |
| 210003312 | 210008930 | null | null | null | 2018-05-07 | 2018-08-07 | Abemaciclib | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100032054 |
| 210003313 | 210008931 | 1.5 | 79.7 | Palliative (P) | 2017-11-05 | 2018-04-07 | Pertuzumab (Loading) | 02 | N | PERTUZUMAB | 101271455 |
| 210003315 | 210008933 | 1.53 | 59 | null | 2016-11-20 | 2019-08-09 | null | N | null | LETROZOLE + PALBOCICLIB | 101120071 |
| 210003319 | 210008935 | 1.52 | 55.4 | Neo-adjuvant (N) | 2018-04-11 | 2018-06-04 | null | 02 | N | ATEZOLIZUMAB + NAB-PACLITAXEL | 100875292 |
| 210003321 | 210008937 | 1.7 | 87.5 | Palliative (P) | 2018-01-01 | 2018-03-20 | Letrozole + Palbociclib | 02 | N | CARBOPLATIN + PACLITAXEL | 101657966 |
| 210003325 | 210008939 | 1.58 | null | Curative (C) | null | 2019-04-20 | ABEMACICLIB + FULVESTRANT | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100793026 |
| 210003326 | 210008940 | 1.42 | 68.2 | Adjuvant (A) | 2019-03-15 | 2019-04-11 | null | 02 | N | PACLITAXEL + TRASTUZUMAB | 101671812 |
| 210003328 | 210008942 | 1.64 | 61.6 | Adjuvant (A) | 2019-04-22 | 2019-05-06 | Neratinib | 02 | N | NERATINIB | 101346546 |
| 210003330 | 210008943 | 1.56 | 82.5 | null | null | 2018-08-17 | ABEMACICLIB + FULVESTRANT | 02 | null | CARBOPLATIN + DOCETAXEL | 101288731 |
| 210003333 | 210008946 | null | null | null | 2019-09-14 | 2019-09-21 | Palbociclib | null | null | PALBOCICLIB | 100273998 |
| 210003335 | 210008948 | 1.74 | 63.8 | Palliative (P) | 2019-10-02 | 2019-11-18 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101207620 |
| 210003338 | 210008950 | 1.56 | 62.45 | null | 2016-04-29 | 2016-08-06 | Palbociclib | 02 | null | EPIRUBICIN | 101047007 |
| 210003339 | 210008951 | 1.64 | null | null | null | 2016-12-08 | null | 02 | null | TRIAL | 101171326 |
| 210003340 | 210008952 | 1.66 | 58.1 | Adjuvant (A) | 2020-12-03 | 2021-07-16 | Palbociclib | 02 | N | EPIRUBICIN | 101216382 |
| 210003341 | 210008953 | null | null | null | 2018-08-30 | 2018-12-02 | Trial Unspecified | 02 | null | EC | 101829987 |
| 210003342 | 210008954 | 1.63 | 69 | Neo-adjuvant (N) | 2018-11-15 | 2018-11-15 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100510666 |
| 210003344 | 210008955 | 1.62 | 64.7 | Adjuvant (A) | 2017-11-29 | 2017-12-09 | EC | null | N | EC | 100143902 |
| 210003345 | 210008956 | 1.65 | 54.6 | Adjuvant (A) | 2014-07-26 | 2014-08-08 | null | 01 | N | ATEZOLIZUMAB + NAB-PACLITAXEL | 101358621 |
| 210003348 | 210008958 | null | null | null | 2019-11-04 | 2019-11-04 | FEC 100 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100405639 |
| 210003352 | 210008960 | 1.85 | 83.5 | Adjuvant (A) | 2016-11-10 | 2016-12-30 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100260471 |
| 210003353 | 210008961 | 1.6 | 127.9 | null | 2018-09-01 | 2018-09-17 | ATEZOLIZUMAB + NAB PACLITAXEL | 02 | null | FULVESTRANT + PALBOCICLIB | 100093309 |
| 210003357 | 210008965 | null | null | null | 2016-12-03 | 2017-08-25 | Eribulin | 02 | null | ERIBULIN | 101870436 |
| 210003358 | 210008966 | 1.65 | 86.3 | Neo-adjuvant (N) | 2016-07-03 | 2016-10-16 | Neratinib | null | N | NERATINIB | 100534008 |
| 210003361 | 210008968 | 1.68 | 71 | Neo-adjuvant (N) | 2016-12-09 | 2017-01-22 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100315102 |
| 210003362 | 210008969 | 1.54 | 69.7 | null | 2018-06-21 | 2018-12-26 | Capecitabine | null | null | CAPECITABINE | 100603558 |
| 210003363 | 210008970 | 1.65 | 56.7 | null | null | 2020-03-02 | PERTUZUMAB + TRASTUZUMAB | null | null | PERTUZUMAB + TRASTUZUMAB | 100754558 |
| 210003365 | 210008972 | null | 54.2 | null | 2018-06-06 | 2018-08-29 | DOCETAXEL + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101816143 |
| 210003367 | 210008973 | null | 107.2 | null | null | 2019-05-25 | EC | 02 | null | EC | 101819454 |